Comerica Bank Bio N Tech Se Transaction History

Comerica Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$118.43 - $186.05 $1,539 - $2,418	-13 Reduced 0.31%	4,147 $0
Q3 2022 Oct 28, 2022	BUY	$127.65 - $183.11 $46,209 - $66,285	362 Added 9.53%	4,160 $561,000
Q2 2022 Aug 02, 2022	SELL	$123.25 - $186.24 $3,327 - $5,028	-27 Reduced 0.71%	3,798 $625,000
Q1 2022 Apr 27, 2022	SELL	$126.25 - $231.85 $5,176 - $9,505	-41 Reduced 1.06%	3,825 $652,000
Q4 2021 Feb 18, 2022	SELL	$216.64 - $362.52 $67,591 - $113,106	-312 Reduced 7.47%	3,866 $996,000
Q3 2021 Nov 22, 2021	SELL	$205.93 - $447.23 $1.89 Million - $4.1 Million	-9,169 Reduced 68.7%	4,178 $1.14 Million
Q2 2021 Aug 26, 2021	SELL	$113.32 - $241.49 $906 - $1,931	-8 Reduced 0.06%	13,347 $2.99 Million
Q1 2021 Apr 28, 2021	BUY	$85.73 - $119.5 $43,122 - $60,108	503 Added 3.91%	13,355 $1.46 Million
Q4 2020 Jan 28, 2021	BUY	$72.71 - $129.54 $45,152 - $80,444	621 Added 5.08%	12,852 $1.05 Million
Q3 2020 Oct 30, 2020	BUY	$57.81 - $104.17 $28,442 - $51,251	492 Added 4.19%	12,231 $846,000
Q2 2020 Jul 31, 2020	BUY	$38.58 - $66.74 $23,379 - $40,444	606 Added 5.44%	11,739 $783,000
Q1 2020 May 01, 2020	BUY	$28.55 - $92.0 $317,847 - $1.02 Million	11,133 New	11,133 $650,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.